Key Bridge Compliance’s Pfizer PFE Stock Holding History

Key Bridge Compliance’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$674K	Buy	+20,334	New	+$719K	0.21%	70

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Key Bridge Compliance's PFE Position: Q3 2023 in Review

Key Bridge Compliance opened a new position in Pfizer (PFE) in Q3 2023: 20,334 shares worth $674K. The stake represents 0.21% of the portfolio and ranks #70 among its holdings.

2,928 funds tracked by Wall St. Rank hold PFE as of Q3 2023.

Key Bridge Compliance held 20,334 shares of Pfizer worth $674K as of Q3 2023.
Pfizer was a new Key Bridge Compliance position in Q3 2023.
Pfizer made up 0.21% of Key Bridge Compliance's portfolio in Q3 2023, its #70 holding.
2,928 funds tracked by Wall St. Rank held Pfizer as of Q3 2023.

Based on Key Bridge Compliance's 13F filing for Q3 2023, filed 13 Oct 2023.